Jove
Visualize
Contact Us

Related Experiment Videos

Understanding the grapefruit-drug interaction.

Dennis Flanagan

    General Dentistry
    |September 15, 2005
    PubMed
    Summary

    Grapefruit juice inhibits CYP3A4 drug metabolism and P-glycoprotein transport, increasing drug bioavailability. Clinicians should consider this interaction when prescribing medications metabolized by CYP3A4.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Persistent Cold-Sensitivity in Root Canal Treated Teeth: Mechanisms, Cracked Roots, and Clinical Implications.

    Clinical, cosmetic and investigational dentistry·2026
    Same author

    Minimum dataset with integrated scoring and indexing methods for soil quality assessment.

    PloS one·2026
    Same author

    Periosteum as a Barrier Membrane.

    The Journal of oral implantology·2025
    Same author

    Canalis Sinuosis: Implications in Implant Dentistry.

    The Journal of oral implantology·2025
    Same author

    Dental Implants: Adjacent Tooth Proximity and Contact.

    The Journal of oral implantology·2025
    Same author

    Horizontal Alveolar Ridge Splitting and Expansion.

    The Journal of oral implantology·2024
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies

    Area of Science:

    • Pharmacology
    • Drug Metabolism
    • Biochemistry

    Background:

    • The enzyme Cytochrome P450 3A4 (CYP3A4) metabolizes over 60% of oral medications.
    • Grapefruit juice interactions with CYP3A4 medications were first identified in 1989.
    • CYP3A4 and P-glycoprotein are key in drug absorption and systemic bioavailability.

    Purpose of the Study:

    • To highlight the significant impact of grapefruit juice on drug metabolism.
    • To inform healthcare providers about potential drug interactions.
    • To emphasize the importance of considering CYP3A4 pathways in pharmacotherapy.

    Main Methods:

    • Review of existing literature on grapefruit juice and drug metabolism.
    • Analysis of the mechanisms of CYP3A4 inhibition and P-glycoprotein transport interference.
    • Identification of common drugs affected by this interaction.

    Main Results:

    • Grapefruit components inhibit both CYP3A4-mediated drug oxidation and P-glycoprotein drug transport.
    • This inhibition leads to increased systemic bioavailability of numerous orally administered drugs.
    • Specific examples include midazolam, triazolam, and diazepam.

    Conclusions:

    • The interaction between grapefruit juice and CYP3A4 substrates necessitates careful consideration in clinical practice.
    • Prescribers must be aware of this interaction to prevent adverse drug events.
    • Understanding grapefruit's effect on drug metabolism is crucial for patient safety.

    Related Experiment Videos